Security key
68622P109
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)
CUSIP: 68622P109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 105,956,500
- Total 13F shares
- 106,492,104
- Share change
- +12,976,655
- Total reported value
- $1,277,897,818
- Put/Call ratio
- 492%
- Price per share
- $12.00
- Number of holders
- 151
- Value change
- +$159,574,138
- Number of buys
- 89
- Number of sells
- 56
Report period
Q3 2025
Institutions
151
Top holders
10
ORIC full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Oric Pharmaceuticals, Inc. SEC filings
Oric Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68622P109
Recent filing periods:
Top shareholders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nextech Crossover I GP S.a r.l. |
13D/G
|
— |
8.4%
|
7,162,637
|
$78,072,743 | $0 | 30 Jun 2025 | |
| EcoR1 Capital, LLC |
13D/G
13F
|
Company |
6.9%
|
6,728,116
|
$73,336,464 | $0 | 29 Jul 2025 | |
| SR ONE CAPITAL MANAGEMENT, LLC |
13D/G
|
— |
4.8%
|
4,615,384
|
$50,307,686 | $0 | 12 Aug 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
4.6%
|
4,504,096
|
$54,049,152 | $0 | 30 Sep 2025 | |
| COLUMN GROUP II, LP |
13D/G
3/4/5
|
Peter Svennilson · 10%+ Owner |
3.7%
|
3,644,118
|
$48,612,534 | $0 | 30 Sep 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
3.5%
from 13D/G
|
2,470,057
|
$25,071,079 | — | 30 Jun 2025 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
James N. Topper |
2%
|
1,410,193
|
$7,981,692 | $0 | 31 Mar 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
6.8%
|
7,162,637
|
$72,700,766 | — | 30 Jun 2025 | |
| Venrock Adviser, LLC |
13F
|
Company |
6.2%
|
6,596,885
|
$66,958,383 | — | 30 Jun 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
6.2%
|
6,572,700
|
$66,712,905 | — | 30 Jun 2025 | |
| PFIZER INC |
13F
3/4/5
|
Company · 10%+ Owner |
5.1%
|
5,376,344
|
$54,569,892 | — | 30 Jun 2025 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
4.3%
|
4,514,929
|
$45,826,529 | — | 30 Jun 2025 | |
| NEA Management Company, LLC |
13F
|
Company |
3.9%
|
4,118,621
|
$41,804,003 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.8%
|
4,077,985
|
$41,391,547 | — | 30 Jun 2025 | |
| Column Group LLC |
13F
|
Company |
3.3%
|
3,540,777
|
$35,938,887 | — | 30 Jun 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
3%
|
3,126,604
|
$31,735,031 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
3,124,693
|
$31,715,634 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
2,850,641
|
$28,934,005 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
2,762,915
|
$28,044,000 | — | 30 Jun 2025 | |
| First Turn Management, LLC |
13F
|
Company |
1.9%
|
2,009,923
|
$20,400,718 | — | 30 Jun 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,800,829
|
$18,278,414 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.7%
|
1,777,744
|
$18,044,102 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.6%
|
1,729,378
|
$17,553,187 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,632,116
|
$16,565,977 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
1,402,768
|
$14,238,095 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,335,448
|
$13,554,797 | — | 30 Jun 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.2%
|
1,278,454
|
$12,976,308 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.2%
|
1,250,000
|
$12,687,500 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,108,460
|
$11,253,130 | — | 30 Jun 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1%
|
1,065,334
|
$10,813,140 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.98%
|
1,042,558
|
$10,581,964 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.95%
|
1,007,575
|
$10,226,886 | — | 30 Jun 2025 | |
| Euclidean Capital LLC |
13F
|
Company |
0.93%
|
989,410
|
$10,042,512 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
951,433
|
$9,657,045 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.85%
|
899,281
|
$9,127,702 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.67%
|
714,866
|
$7,256,643 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.46%
|
489,637
|
$4,969,816 | — | 30 Jun 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.46%
|
485,629
|
$4,929,134 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
400,954
|
$4,069,684 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.37%
|
394,785
|
$4,007,068 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.37%
|
394,693
|
$4,006,134 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
382,389
|
$3,881,248 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
365,400
|
$3,708,810 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
350,535
|
$3,557,930 | — | 30 Jun 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.33%
|
344,922
|
$3,500,958 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
298,442
|
$3,029,186 | — | 30 Jun 2025 | |
| Atom Investors LP |
13F
|
Company |
0.24%
|
252,653
|
$2,564,428 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.23%
|
244,368
|
$2,480,335 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.22%
|
234,774
|
$2,382,956 | — | 30 Jun 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
231,485
|
$2,349,573 | — | 30 Jun 2025 |
Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q3 2025
As of 30 Sep 2025,
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,492,104 shares.
The largest 10 holders included
Nextech Invest, Ltd., EcoR1 Capital, LLC, VR ADVISER, LLC, VIKING GLOBAL INVESTORS LP, Pfizer Inc, BlackRock, Inc., VANGUARD GROUP INC, SR One Capital Management, LP, ALKEON CAPITAL MANAGEMENT LLC, and NEA Management Company, LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
140
Q3 2025 holders
151
Holder diff
11
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.